Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas RJ Atkins, J Dimou, L Paradiso, AP Morokoff, AH Kaye, KJ Drummond, ... Journal of Clinical Neuroscience 19 (11), 1558-1563, 2012 | 72 | 2012 |
Repair mechanisms help glioblastoma resist treatment RJ Atkins, W Ng, SS Stylli, CM Hovens, AH Kaye Journal of clinical neuroscience 22 (1), 14-20, 2015 | 68 | 2015 |
Glycogen synthase kinase-3β (GSK-3β) and its dysregulation in glioblastoma multiforme RJ Atkins, SS Stylli, RB Luwor, AH Kaye, CM Hovens Journal of Clinical Neuroscience 20 (9), 1185-1192, 2013 | 46 | 2013 |
Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance RJ Atkins, SS Stylli, N Kurganovs, S Mangiola, CJ Nowell, TM Ware, ... Experimental cell research 374 (2), 353-364, 2019 | 41 | 2019 |
Identification and isolation of slow-cycling glioma stem cells L Furst, RJ Atkins, M Dinevska, SS Stylli, NM Corcoran, CM Hovens, ... Methods in Cell Biology 170, 21-30, 2022 | 2 | 2022 |
Role of cell quiescence in glioblastoma cytotoxic resistance and strategies for therapeutic intervention RJ Atkins, SS Stylli, NM Corcoran, CM Hovens, T Mantamadiotis Glioblastoma Resistance to Chemotherapy: Molecular Mechanisms and Innovative …, 2021 | | 2021 |
Abstract B38: Quiescence as a marker of treatment resistance and malignancy in GBM RJ Atkins, SS Stylli, RB Luwor, TMB Ware, AH Kaye, CM Hovens Molecular Cancer Research 14 (4_Supplement), B38-B38, 2016 | | 2016 |
Glycogen synthase kinase-3b (GSK-3b) and its dysregulation in glioblastoma multiforme RJ Atkins, SS Stylli, RB Luwor, AH Kaye, CM Hovens | | 2013 |